See All Slides - tctmd.com

Slides

Presentation TCT 2013

Introducing the Case(4)

Presenter: Feng-Yu Kuo

October 30, 2013

Presentation TCT 2013

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Case Presentation 1: My Most Difficult Retrograde Approach Case in 2013

Presenter: R. Michael Wyman

October 30, 2013

Presentation TCT 2013

ACCESS EU Insights: Are the Randomized Trial Results Translatable?

Presenter: Olaf Franzen

October 30, 2013

Presentation TCT 2013

The MitraClip Procedure: When to Use Two or More Clips

Presenter: Ralph von Bardeleben

October 30, 2013

Presentation TCT 2013

How Did I Treat This Patient (And How Did It Turn Out)?(2)

Presenter: Shih-Hsien Sung

October 30, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

Presentation TCT 2013

Case VI: Neoatherosclerosis and Treatment

Presenter: Maoto Habara

October 30, 2013

Presentation TCT 2013

TCT-123. Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission

Presenter: Gilles Montalescot

October 30, 2013

Presentation TCT 2013

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Presenter: Stephan Windecker

October 30, 2013

Advertisement

Slides

Introducing the Case(4)

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

Case Presentation 1: My Most Difficult Retrograde Approach Case in 2013

ACCESS EU Insights: Are the Randomized Trial Results Translatable?

The MitraClip Procedure: When to Use Two or More Clips

How Did I Treat This Patient (And How Did It Turn Out)?(2)

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Case VI: Neoatherosclerosis and Treatment

TCT-123. Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content